iifl-logo

Dr Agarwals Eye Hospital Ltd Board Meeting

4,448.8
(-13.54%)
Aug 28, 2025|12:00:00 AM

Dr Agarwals Eye CORPORATE ACTIONS

29/08/2024calendar-icon
29/08/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting27 Aug 202524 Aug 2025
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2025 inter alia to consider and approve the proposal for raising of funds up to ? 700000000 (Indian Rupees seventy crores only) by issuance of equity shares of the Company to Dr. Agarwals Health Care Limited (promoter of the Company) by way of preferential allotment in accordance with the provisions of the Companies Act 2013 SEBI Listing Regulations SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and other applicable laws and subject to such regulatory/ statutory approvals and the approval of shareholders of the Company as may be required in this regard.
Board Meeting12 Aug 202530 Jul 2025
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the unaudited financial results for the quarter ended June 30 2025. As per the letter enclosed. (As Per BSE Announcement Dated on: 12/08/2025)
Board Meeting28 May 202520 May 2025
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2025 and recommendation of Final Dividend if any for the Financial Year 2024-25. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. As per the letter enclosed. (As per BSE Announcement Dated on 28/05/2025)
Board Meeting14 Feb 20257 Feb 2025
DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2024 As per the letter enclosed. (As Per BSE Announcement Dated on 14.02.2025)
Board Meeting29 Oct 202423 Oct 2024
DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter and half-year ended 30th September 2024. DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 ,inter alia, to consider and approve Update on board meeting (As per BSE Announcement Dated on 24/10/2024) Outcome of Board Meeting is submitted (As per BSE Announcement Dated on 29/10/2024)

Dr Agarwals Eye: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.